Evidence map›Paper›PMID 26221306›Full record

ArticleInternational journal of clinical and experimental medicine2015

Modified glasgow prognostic score predicting high conversion ratio in opioid switching from oral oxycodone to transdermal fentanyl in patients with cancer pain.

Shu-Shan Jia, Li Shang, Ming-E Li, Dong-Mei Zhao, Wen-Hua Xu, Yao-Qi Wang

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Shu-Shan JiaDepartment of Anesthesiology, Affiliated Hospital of Binzhou Medical University, No. 661, Yellow-River Second Street, Binzhou 256603, People's Republic of China.
Li ShangDepartment of Nursing, Affiliated Yantai Hospital of Binzhou Medical University No. 629, Nan-Hua Street, Yantai 264000, People's Republic of China.
Ming-E LiDepartment of Physical Examination, Affiliated Hospital of Binzhou Medical University No. 661, Yellow-River Second Street, Binzhou 256603, People's Republic of China.
Dong-Mei ZhaoDepartment of Anatomy, Binzhou Medical University No. 661, Yellow-River Second Street, Binzhou 256603, People's Republic of China.
Wen-Hua XuDepartment of Nursing, Affiliated Yantai Hospital of Binzhou Medical University No. 629, Nan-Hua Street, Yantai 264000, People's Republic of China.
Yao-Qi WangDepartment of Anesthesiology, Affiliated Hospital of Binzhou Medical University, No. 661, Yellow-River Second Street, Binzhou 256603, People's Republic of China.
Binzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to identify predictive factors for higher conversion ratio in opioid switching from oral oxycodone to transdermal fentanyl (TDF) in patients with cancer pain. The participants of this study were 156 hospitalized cancer patients who underwent opioid switching from oral oxycodone to TDF at the Affiliated Hospital of Binzhou Medical University between January 1st, 2010 and March 31st, 2014. Patient characteristics, modified Glasgow Prognostic Score (mGPS), daily oxycodone dose, and reasons for opioid switching were retrospectively collected. The effect of variables on the conversion ratio was analyzed by multiple regression analysis to identify the predictive factors for higher conversion ratio in opioid switching from oral oxycodone to TDF. The results showed that the mGPS (odds ratio [OR], 2.358; 95% CI 1.379-4.031; P = 0.002), the reason for opioid switching (OR, 0.497; 95% CI, 0.298-0.828; P = 0.007) and equivalent oral morphine dose (OR, 1.700; 95% CI, 1.008-2.867; P = 0.046) were found to be significant predictors requiring higher conversion ratio in opioid switching. This study indicates that higher mGPS, poor pain control before switching and higher equivalent oral morphine dose are significant predictors of a need for higher conversion ratio in opioid switching from oral oxycodone to TDF. These results could contribute to the establishment of evidence-based medicine in cancer pain relief.

Indexed as

cancer painconversion ratioopioid switchingoxycodoneTransdermal fentanyl

Identifiers

PMID26221306
PMCPMC4509251
OpenAlexW2414835023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.